IMMUNOLOGICAL CONCEPT OF CANCER BRDICJOURNAL The concept arose step by step directly from our initial observations on the non-carcinogenic tumour-inhibiting substances in coal-tar. It was developed as a basis for planned experimental work and as such has proved most useful. I am much indebted to Burnet's stimulating idea of "selfmarkers," which, extended into the cancer field, provided at a later stage an essential link in the hypothesis. Summary Non-carcinaogenic polycyclic hydrocarbons which strongly inhibited the growth of some transplanted tumours were isolated from coal-tar oil.
These compounds, as compared with related carcinogenic hydrocarbons, were non-toxic and did not inhibit somatic growth. Nevertheless their tumour-inhibiting effect was shown to be of the same specific nature as that induced by the carcinogens. Neither had any direct cytotoxic effect on the tumour.
Both types failed to inhibit spontaneous or chemically induced tumours, or transplanted tumours lacking antigenicity to the host.
It was conclusively shown, partly with the aid of cortisone, that the tumour-inhibiting property was due to a stimulation of the immune reaction to homologous tumour tissue.
Evidence is presented which favours the view that these compounds have the specific property of altering certain protein complexes so that they behave as iso-antigens and excite the production (mainly locally) of homologous antibody. Their mode of action is discussed and the important role of the plasma cell in the immune response demonstrated.
Some evidence was obtained that chemical carcinogens when in intimate contact with red cells and epidermal cells induce the production of homologous antibodies to iso-antigens in similar cells.
Evidence is presented suggesting that tumour-inhibiting and carcinogenic capacity are biologically closely related. It is therefore postulated that the immune reaction induced by a carcinogen is the essential primary stage in chemical carcinogenesis.
It is suggested that all the tumour-inhibiting polycyclic hydrocarbons are able to induce the primary " initiation " stage, but that only the carcinogens are able to " promote " the cell to the stage of neoplasia by their additional non-specific hyperplastic action.
It is postulated that the " initiation " stage of chemical carcinogenesis is that at which an antigenic change in the " identity protein(s) " to an iso-antigen occurs. The antibody response thus elicited either destroys the precancerous cell at some stage, or continuous hyperplasia leads to an ever-increasing immune reaction which may finally induce an adaptation in the cell. The adaptation involves the loss of " identity-protein " complexes, and the neoplastic cell emerges.
Evidence (Loeser, 1938a (Loeser, , 1938b -is now a well-established method of influencing inoperable growth and recurrence. But I, like many others, was not entirely satisfied. From 1950 onwards (Loeser, 1950 , 1951 , 1953 , 1953 I got much better results by combining the male hormone with thyroid hormone, and described this method in cases of inoperable breast cancer at the International Cancer Congress in Paris (Loeser, 1950 (Frankland, Pepys, com- piled by Loeser) .. 2. Hyperthyroidism (Lerman, 1947) .. 3. Myxoedema (Lerman, 1947) .. 4. After thyroidectomy (Buxton and Willcox, 1952) .. 5. After thyroidectomy (Ellerker and Loeser*) 6. Goitre and conditions after thyroidectomy (Repert, 1952) (1953) .
The question arises, How does the thyroid hormone act as an anticarcinogen ? If patients receive small or moderate amounts of thyroid over a prolonged period, these patients' own thyroid glands can be put to rest, because of a decreased secretion of thyrotropic hormone by the anterior pituitary (Loe1S, 1920; Johnston, 1951 (Levitt, 1954) .
If a carcinogen (dibenzanthracene) is injected into mice it produces tumours, but if this carcinogen is injected together with thyroxine, the rate of disappearance of the carcinogen from the tissues is increased and the tumour response is lowered. Thiouracil, on the other hand, greatly increases the incidence of dibenzanthracene-produced tumours. Thyroxine had little or no effect upon the growth of already established dibenzanthracene-produced tumours (Bather and Francks, 1952) .
Thyroxine plays an important part in the normal cell defence by increasing the metabolic destruction of the carcinogen. It is essential for basic cell metabolism, controlling cell respiratory catalysts, and enzymatic action. Practically every chemical reaction which occurs in the body is an enzyme reaction. These enzymes, these catalytic proteins, are living matter dependent on the thyroid content in the blood. As far back as 1932 I could show. in the Warburg experiment, that the cell metabolism of placenta and benign and malignant tumours could be influenced by hormones.
I shall now deal with the work I have done in collaboration with many others in London hospitals.
Clinical Observations
One hundred patients who had previously undergone a partial thyroidectomy were followed up by Mr. Ellerker, of the Royal Free Hospital, London, and mxself (Table I) . Among these we found seven with cancer development (one of the cervix, six of the breast). All these cancer growths had been removed by radical operation some years after a preceding thyroidectomy for goitre, and the patients were alive at the time of re-examination. Among the remaining 93 thyroidectomized cases, 32 had developed a chronic mastitis (endocrine basis) or fibroids of the uterus. These 32 cases had never received thyroid hormone after thyroidectomy. But among the then remaining 61 patients were 14 who had received thyroid hormone after thyroidectomy, and in only four could a chronic mastitis be diagnosed.
This fact shows that a lack of thyroid hormone in the body favours tumour development. The defence mechanism against tumour formation cannot be maintained when there is insufficient thyroid hormone, whatever the cause for this deficiency may be. After an intensive burn a scar has little histamine. Years after such a burn a local skin cancer may develop. In the skin round a precancerous hyperkeratosis practically no histamine was found by contrast with the skin further away from the scar, where much histamine was found. In the skin through which deep x rays had penetrated the histamine was very much diminished. Could smoking perhaps also reduce the cell histamine content in the lung ?
For our purpose a piece of the skin was removed from patients, and within 60 minutes the extract of the fresh, living skin was assayed against histamine on the atropinized guinea-pig's ileum preparation. There is no doubt that hypothyroid persons show much less histamine than the hyperthyroid (Table II) Thzere is a quantititative relationshlip betweeni the amnoumait of thiyroid hlormonie produced in the human body or artificially incorporated by thyroid treatment and the intracellullar deposition of histaminie. The histamine content in the cells is conitrolled by the thyroid hlormone. The more thyroid hormone, the inore histamiinle, the lower the level of lipids in the bloodl. The less thyroid hormonte, the less histamine, and the hiigher the blood lipid level.
These facts are significant, since cancer develops more often in hypothyroid, non-allergic, and obese women of the 40-60 age group than in allergic or hyperthyroid women of the safe age group. endometrial cancer on the borderline of operability; and (c) two breast-cancer cases with axillary gland involvement. Both of them had post-operative deep x-ray treatment. Three of the four patients were overweight; all of them had plasma cholesterol over 280 mg./ml. The fouLr patients --re now in good health and clinically cured. In th_ ovarian-cancer case a mediastinal tumour appearing in the sixth year after the beginning of the thyroid treatment proved to be a thymoma which disappeared completely after deep x-ray treatment.
Of a further 14 women who were observed for more than four years after radical mastectomy, nine were overweight. An axillary gland involvement existed at the time of the operation in 10 of them ; four had no axillary involvement. All were scirrhous carcinomata, and in all but three the plasma cholesterol was over 260 mg./ml. Only one of these 14 women had a recurrence-this was in the brain, and it caused her death.
Thus there were l 8 cases in all, with only one certain recurrence.
Far be it from me to draw any conclusion from the examination of these two small groups, and I will not even report on my other series of cases which have been observed over a period of only one to three years since the beginning of thyroid treatment. Such a small series may lead to erroneous deduction. and observation for less than five years is too short for a real evaluation of whether or not thyroid treatment has inhibited new cancer formation.
I think, however, that the results warrant the use of prophylactic thyroid hormone treatneent, and I hope that many will try it against cancer recurrence. Only examinations on a large scale will show the real value of this method.
Summary
The incidence of female breast and genital cancer is far lower in allergic and hyperthyroid conditions (Group A) than in hypothyroid women or women after a partial thyroidectomy because of goitre (Group B).
Women belonging to Group A have on average a much higher histamine content in their cells than women in Group B, and the lipid content of the blood is much lower in Group A than in Group B.
The more thyroid hormone circulating in the blood the higher the histamine content in the cells, the lower the level of the lipids the less tendency to cancer formation.
The less thyroid hormone circuilating in the blood the lower the histamine content in the cells, the higher the level of the lipids the more tendency to cancer formation.
Intracellular protein-bound histamine is regar-ded as a d&fence hormone against cancer formation under the control of the thyroid hofmone.
Thyroid hormone, given in massive dosage in cases of inoperable cancer of the breast and genitals, slowed down cancer growth.
Thyroid hormone in daily dosage ranging between 1 and 5 gr. (65 anid 320 mg.) was given over six years as a prophylactic against cancer recurrence after radical operations because of breast or genital cancer, and after deep x-ray treatment. The good results which were obtained should encourage further trial of this method on a large scale.
